The Translational Breast Cancer Research Consortium was well represented at the 2020 SABCS Meeting. Presentations included:

TBCRC 038: The Human Tumor Atlas Network (HTAN) Breast PreCancer Atlas:  A multi-omic integrative analysis of ductal carcinoma in situ (DCIS) and correlation with clinical outcomes; Abstract: #PD5-08

Randomized Phase II Trial to Evaluate Alisertib Alone or Combined with Fulvestrant for Advanced, Endocrine-resistant Breast Cancer (TBCRC 041); Abstract #PD2-05

TBCRC 044: Randomized phase II study of pembrolizumab and carboplatin versus carboplatin alone for chest wall recurrence of breast cancer; Abstract #OT-13-09